PLN-74809, a clinical-stage, dual alphaVbeta6/alphaVbeta1 integrin inhibitor, reduces fibrosis in a preclinical model of biliary fibrosis and precision-cut liver slices from primary sclerosing cholangitis and primary biliary cholangitis patients
Journal of Hepatology（2020）
Key words
biliary fibrosis,alphavbeta6/alphavbeta1 integrin inhibitor,primary biliary cholangitis patients,clinical-stage,precision-cut
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined